Does the DIO2 rs225014 CT genotype reduce tissue T4-to-T3 activation?

The DIO2 rs225014 (Thr92Ala) polymorphism directly influences type II deiodinase (D2), the primary enzyme responsible for converting thyroxine (T4) into biologically active triiodothyronine (T3) within tissues.

Impact on T4-to-T3 activation

• Enzyme efficiency: The heterozygous CT (Thr/Ala) genotype results in a moderate, dose-dependent reduction in tissue-level T4-to-T3 conversion compared to the wild-type TT genotype.
• Cellular mechanisms: The Ala92-D2 protein variant exhibits a 20% to 40% reduction in in vivo catalytic activity. This impairment is driven by altered cellular trafficking, folding, and proteasomal handling rather than shifted baseline enzymatic kinetics.
• Clinical presentation: While individuals with intact thyroid function typically compensate to maintain normal serum hormone levels, this enzymatic restriction becomes clinically apparent in thyroid-deficient patients on levothyroxine (LT4) monotherapy, who often present with lower systemic T3/T4 ratios.

Response to physiologic stress

• Heterozygote advantage: During acute physiologic stress—such as sepsis, acute lung injury (ALI), and severe infections like COVID-19—the CT genotype exhibits a protective, overdominant effect.
• Clinical outcomes: Rather than increasing vulnerability, clinical cohorts show that the heterozygous CT genotype is associated with a significantly reduced risk of severe sepsis, acute lung injury, and in-hospital mortality compared to homozygous (TT and CC) peers.
• Tissue preservation: The intermediate D2 activity of the CT genotype balances localized T3 production, mitigating cellular endoplasmic reticulum (ER) stress and preserving skeletal muscle mass while reducing myosteatosis during acute illness.

Bottom line

• While the DIO2 rs225014 CT genotype moderately reduces baseline tissue-level T4-to-T3 conversion, under acute physiologic stress it confers a protective "heterozygote advantage," balancing local thyroid hormone availability and mitigating cellular stress to improve clinical survival and tissue outcomes.